[Halothane or enflurane treatment in life-threatening asthma]

Area of Science:

• Anesthesiology
• Pulmonology
• Critical Care Medicine

Context:

• Severe, life-threatening asthma often requires advanced interventions beyond standard pharmacological treatments.
• Persistent hypoxemia, hypercapnia, high airway pressures, and clinical exhaustion indicate a need for alternative therapeutic approaches.
• Bronchial toilet using a bronchoscope is a critical component in managing severe asthma exacerbations.

Purpose:

• To evaluate the efficacy and safety of inhalation anesthetic therapy as a rescue treatment for severe asthma.
• To determine appropriate anesthetic concentrations for managing life-threatening asthma exacerbations.
• To assess the occurrence of major complications associated with this therapeutic approach.

Summary:

• Six patients with severe asthma received inhalation anesthetic therapy when standard treatments failed.
• Halothane (1.0-2.0%) or enflurane (1.0-4.2%) was administered, with therapy initiated based on specific clinical and physiological criteria.
• No major complications were reported during the administration of inhalation anesthetic therapy.

Impact:

• Inhalation anesthetic therapy may represent a viable option for managing refractory severe asthma.
• This study provides preliminary data on the safe application of specific anesthetic agents and concentrations in critical asthma cases.
• Further research is warranted to establish the definitive role and long-term outcomes of this intervention in severe asthma management.